Clinical Trial Results

Showing: All studies [change]
Condition: Obesity Location: Tustin, California 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
PHASE2INTERVENTIONAL Pelham, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
PHASE3INTERVENTIONAL Canoga Park, California +4 more
RECRUITING
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
PHASE3INTERVENTIONAL Tempe, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
PHASE3INTERVENTIONAL Pelham, Alabama +4 more
RECRUITING
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
PHASE3INTERVENTIONAL Covina, California +4 more
RECRUITING
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
PHASE4INTERVENTIONAL Orange, California
RECRUITING
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
NAINTERVENTIONAL Orange, California +1 more
RECRUITING
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
PHASE3INTERVENTIONAL Guntersville, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
PHASE3INTERVENTIONAL Alexander City, Alabama +4 more
RECRUITING
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PHASE4INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type